hydrogel technology

18
Internship surgery ’73 - ’83 ’84 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ‘03 ‘05 ‘07 ‘09 ‘11 Children’s Hospital of Eastern Ontario experimental spinal cord injury (SCI) Neurobiology Res Ctr QC Res Ctr in Science & Macromol Eng biomaterials concept for neuroregeneration Keele University polymer drug delivery Prague Institute of Macromol Chemistry bioactive hydrogel formulation & dev. Quebec Biomaterial Institute adjunct faculty invention of Neurogel as novel approach to SCI Organogel Canada Ltd Organogel Canada Ltd CERMAV-CNRS GIN- Inserm program directorbioretina glycosylated hydrogels neural stem cell recruitment France Canada uk Czech Rep. Canada France EMPLOYMENT Areas represent relative energy expenditure over time RESUME/ROADMAP INFOGRAPHIC Stéphane Woerly MD PhD Medical Research Council Fellowship ACADEMICS Pie slices represents approx. percentage time investment graduati on MD training neurochemistry graduation Polymeric biomaterials Neurodegenerati on Neuroregenerati on physical-chemistry polymerization process Hydrogel chemistry CSOexperimental surgery preclinical proof- of-concept on established SCI models creation of Organogel Canada Ltd Quebec Metro High Tech Park fundraising/IP development CMOclinical master file new treatment option to SCI endogenous regenerative technology Neuro polymer professional Neurogel development (biomaterials ‘90)

Upload: stephane-woerly-md-phd

Post on 05-Dec-2014

904 views

Category:

Health & Medicine


2 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Hydrogel   Technology

Internship surgery

’73 - ’83 ’84 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ‘03 ‘05 ‘07 ‘09 ‘11

Children’s Hospital of Eastern Ontario experimental spinal cord injury (SCI)

Neurobiology Res Ctr QC Res Ctr in Science & Macromol Eng biomaterials concept for neuroregeneration

Keele University polymer drug delivery

Prague Institute of Macromol Chemistry bioactive hydrogel formulation & dev.

Quebec Biomaterial Institute adjunct faculty invention of Neurogel as novel approach to SCI

Organogel Canada Ltd

Organogel Canada Ltd

CERMAV-CNRS GIN-Inserm program directorbioretina glycosylated hydrogels neural stem cell recruitment

France Canada uk Czech Rep. Canada France

EMPLOYMENT

Areas represent relative energy expenditure over timeRESUME/ROADMAP INFOGRAPHIC Stéphane Woerly MD PhD

Medical Research Council Fellowship

ACADEMICS

Pie slices represents approx. percentage time investment

graduation

MD training neurochemistry

graduation

Polymeric biomaterialsNeurodegenerationNeuroregeneration

physical-chemistrypolymerization processHydrogel chemistry

CSOexperimental surgery preclinical proof-of-concept on established SCI models

creation of Organogel Canada LtdQuebec Metro High Tech Parkfundraising/IP development

CMOclinical master file new treatment option to SCIendogenous regenerative technology

Neuro polymer professional

Neurogel development

(biomaterials ‘90)

Page 2: Hydrogel   Technology

Macroporous pHPMA Hydrogel

© Copyrights Woerly

A proprietary innovative technology platform with applications in Tissue Neuro-Engineering and RegenMed

A proprietary innovative technology platform with applications in Tissue Neuro-Engineering and RegenMed

Page 3: Hydrogel   Technology

Tissue-building properties

of pHPMA hydrogel

New AstrocyticTissue Matrix

Axonal Growth

Angiogenesis

Signaling moleculecirculation

Stem cell recruitment

Page 4: Hydrogel   Technology

EM Structure imaging of HPMA EM Structure imaging of HPMA hydrogel hydrogel macro/mesoporesEM Structure imaging of HPMA EM Structure imaging of HPMA hydrogel hydrogel macro/mesopores

Cross-linked poly[N-(2-hydroxypropyl) methacrylamide] hydrogel showsa macromolecular architecture with a colloidal-type structure

3D section plot

Volume viewer

Page 5: Hydrogel   Technology

EM Structure imaging of HPMA EM Structure imaging of HPMA hydrogel hydrogel microporesEM Structure imaging of HPMA EM Structure imaging of HPMA hydrogel hydrogel micropores

Micropores on the surface of microgels that increase the surface area of the bulk of the hydrogel network

Page 6: Hydrogel   Technology

in vivo confocal imaging of in vivo confocal imaging of hydrogelhydrogelpolymer/CNS tissue interface

Polymer-tissue interfacePolymer-tissue interface

CNS tissueCNS tissue

Page 7: Hydrogel   Technology

in vivo confocal imaging in vivo confocal imaging (I)(I)immuno-labeling of stem cell migration within the hydrogel intracerebral implantation (4 month post-grafting)

in vivo confocal imaging in vivo confocal imaging (I)(I)immuno-labeling of stem cell migration within the hydrogel intracerebral implantation (4 month post-grafting)

Page 8: Hydrogel   Technology

in vivo confocal imaging (II)in vivo confocal imaging (II)immuno-labeling of stem cell migration within the hydrogel intracerebral implantation (4 month post-grafting)

Page 9: Hydrogel   Technology

in vivo confocal imaging (III)in vivo confocal imaging (III)immuno-labeling of stem cell migration within the hydrogel implanted in the spinal cord (17 month after trauma and post-grafting)

neurofilament/MBP (red) Nestin (green)/MBP(red)

The arrow and the insert show a NF+ neuronal cell body

Page 10: Hydrogel   Technology

in vivo confocal imaging in vivo confocal imaging nerve fibres growth within the hydrogel pore network

in vivo confocal imaging in vivo confocal imaging nerve fibres growth within the hydrogel pore network

Page 11: Hydrogel   Technology

3D hydrogel volume reconstruction 3D hydrogel volume reconstruction cell distribution (red dots) within the pore structure

Page 12: Hydrogel   Technology

in vivo confocal imaging in vivo confocal imaging angiogenesisin vivo confocal imaging in vivo confocal imaging angiogenesis

Growing blood vessels within the polymer network

Page 13: Hydrogel   Technology

in vitro SEM imaging in vitro SEM imaging HPMA hydrogel including human neuroblastoma cells

in vitro SEM imaging in vitro SEM imaging HPMA hydrogel including human neuroblastoma cells

Neurite extending within the polymer

network

Neurite extending within the polymer

network

Cell aggregates Cell aggregates

Page 14: Hydrogel   Technology

in vitro nestin-hoescht imaging in vitro nestin-hoescht imaging hydrogel including primate neural precursor cells *

* source: Stem cell and Brain Research Institut of Lyon

Polymer networkPolymer network

Page 15: Hydrogel   Technology

Key features of NeurogelKey features of Neurogel

• Elastic modulus matches that of CNS

• Tensile strength across the area of transplantation

• Porosity allows cells, growth factors and axonal elongation to fill the lesion site

• Does not breakdown—allows for enough time for regeneration

• Promotes the exclusion of scar tissue and Wallerian degeneration in the transected spinal cord

• flexible platform for the optimization of scaffold functionality

• Good surgical procedure feasibility

Page 16: Hydrogel   Technology

Current developmental statusCurrent developmental status

• Laboratory prototypes• Product Requirement Specifications• Verification & validation• Preclinical Proof-of-concept (SCI)• Toxicology/biocompatibility testing• Sterility assurance• Packaging & stability issues

Page 17: Hydrogel   Technology

Neurotechnology / proof-of-principle

HPMA hydrogel graft acrossa lesion of the spinal cord

Gross anatomy of theimplantation site 15 months post-surgery

Page 18: Hydrogel   Technology

Introduction of a sialyl derivative group (immunolabeled in green) to create specific biological properties

Functionalization of HPMA hydrogel